3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
2
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
6
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Breast Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Nodule
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neuroendocrine Tumor
1
Hyperthyroidism
1
Hip Fractures
1
Hematologic Neoplasms
1
Goiter
1
Glioma
1
Glioblastoma
1
Frailty
1
Fractures, Spontaneous
1
Interventions
Fulvestrant
125
Trastuzumab
114
Paclitaxel
113
Letrozole
108
pembrolizumab
79
pertuzumab
75
palbociclib
75
Capecitabine
74
Anastrozole
72
Cyclophosphamide
70
Carboplatin
67
abemaciclib
64
exemestane
63
Tamoxifen
63
ribociclib
60
trastuzumab deruxtecan
57
Surveys and Questionnaires
51
Specimen Handling
51
Radiotherapy
49
Docetaxel
49
Magnetic Resonance Spectroscopy
48
Blood Specimen Collection
40
olaparib
39
Standard of Care
36
Biopsy
33
sacituzumab govitecan
31
130-nm albumin-bound paclitaxel
31
Doxorubicin
30
Exercise
29
eribulin
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Data Collection
×
1 year
×
Clear all
NCT06240195
2026-06-05
BIO-PROSA
Regina Elena Cancer Institute
Recruiting
60 enrolled
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled